Orthopedic Devices are used to treat the disorders and injuries of the musculoskeletal system of human body. Orthobiologics are biomaterials used in orthopedic surgery as an adjunct to faster fusion and healing of the bone. Bone Growth Stimulators are mainly used to facilitate bone growth in impaired or delayed healing fractures/fusions. GlobalData uses proprietary data and analytics to provide a comprehensive report on the bone growth stimulators devices market, including market shares of different players within Taiwan. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the bone growth stimulators market in Taiwan was Orthofix Holdings Inc followed by DJO Global, ZimVie and Bioventus.
Bone Growth Stimulators apply electrical or ultrasound waves to the site of the fracture/fusion. The usage of the stimulators for the following bones are tracked here: radius, ulna, tibia, fibula, clavicle, scapula, humerus and femur. Bone Growth Stimulators can be either External or Implantable Devices. External Bone Growth Stimulators are the stimulation devices which are worn outside the skin and do not require any surgical intervention. Implantable Bone Growth Stimulators are the stimulation devices which are implanted during surgery to stabilize the fracture.
The value of the bone growth stimulators devices market within Taiwan was expected to be over $0.6m in 2023.
For the latest complete market share analysis of bone growth stimulators device market in Taiwan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.